Nimesh Mody

4.7k total citations · 1 hit paper
48 papers, 3.8k citations indexed

About

Nimesh Mody is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Nimesh Mody has authored 48 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 13 papers in Physiology and 11 papers in Epidemiology. Recurrent topics in Nimesh Mody's work include Protein Tyrosine Phosphatases (17 papers), Retinoids in leukemia and cellular processes (14 papers) and Adipose Tissue and Metabolism (10 papers). Nimesh Mody is often cited by papers focused on Protein Tyrosine Phosphatases (17 papers), Retinoids in leukemia and cellular processes (14 papers) and Adipose Tissue and Metabolism (10 papers). Nimesh Mody collaborates with scholars based in United Kingdom, United States and Sweden. Nimesh Mody's co-authors include Barbara B. Kahn, Timothy E. Graham, Qin Yang, Odile D. Peroni, Frédéric Preitner, Loredana Quadro, Janice M. Zabolotny, Ko Kotani, Mirela Delibegović and Philip Cohen and has published in prestigious journals such as Nature, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Nimesh Mody

47 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

2005 1.7k citations Qin Yang, Timothy E. Graham et al. Nature profile →

Peers

Countries citing papers authored by Nimesh Mody

Since Specialization

Citations

This map shows the geographic impact of Nimesh Mody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nimesh Mody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nimesh Mody more than expected).

Fields of papers citing papers by Nimesh Mody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nimesh Mody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nimesh Mody. The network helps show where Nimesh Mody may publish in the future.

Co-authorship network of co-authors of Nimesh Mody

This figure shows the co-authorship network connecting the top 25 collaborators of Nimesh Mody. A scholar is included among the top collaborators of Nimesh Mody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nimesh Mody. Nimesh Mody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydroxysteroid 17β‐dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high‐fat diet obese mice 2025 ·Experimental Physiology ·(unknown), (unknown), Dawn Thompson, (unknown), (unknown), (unknown), George D. Mcilroy, Justin J. Rochford, Nimesh Mody	5
2	Prevalence and correlates of diagnosed and undiagnosed diabetes mellitus among adults in rural Uganda during the COVID-19 pandemic: an evaluation of a community-based screening programme 2025 ·International Health ·(unknown), Silver Bahendeka, Nimesh Mody, Sara MacLennan, Aravinda Meera Guntupalli	0
3	Evaluation of the Epitogen Lyme Detect IgG ELISA: a novel peptide multiplexing approach 2024 ·Microbiology Spectrum ·Tiehui Wang, Alex Wang, (unknown), (unknown), (unknown), Robin Brittain-Long, Mirela Delibegović, Christopher J. Secombes, Nimesh Mody, Sally Mavin, (unknown)	1
4	Morning exercise and pre‐breakfast metformin interact to reduce glycaemia in people with type 2 diabetes: a randomized crossover trial 2024 ·The Journal of Physiology ·B. J. Carrillo, (unknown), (unknown), (unknown), (unknown), (unknown), Nimesh Mody, Mirela Delibegović, Sam Philip, Frank Thiès, Dimitra Blana, Brendan M. Gabriel	3
5	Diabetes mellitus in sub-saharan Africa during the COVID-19 pandemic: A scoping review 2024 ·PLoS ONE ·(unknown), Silver Bahendeka, Sara MacLennan, Nimesh Mody, Aravinda Meera Guntupalli	1
6	Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism 2023 ·Journal of Translational Medicine ·(unknown), (unknown), Dawn Thompson, (unknown), Sam Philip, Heather M. Wilson, Nimesh Mody, Mirela Delibegović	5
7	Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice 2023 ·Scientific Reports ·Dawn Thompson, (unknown), (unknown), (unknown), (unknown), (unknown), Mary K. Doherty, (unknown), Mirela Delibegović, Nimesh Mody	10
8	Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia 2017 ·Cancer Research ·(unknown), (unknown), (unknown), Dawn Thompson, Mark A. Vickers, Graeme I. Murray, Nimesh Mody, Benjamin G. Neel, Kendra K. Bence, Heather M. Wilson, Mirela Delibegović	39
9	Direct comparison of methionine restriction with leucine restriction on the metabolic health of C57BL/6J mice 2017 ·Scientific Reports ·Emma K. Lees, (unknown), (unknown), Sophie Hill, (unknown), Louise Grant, Nimesh Mody, Mirela Delibegović	51
10	Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE −/− mouse model of atherosclerosis with alterations in IL10/AMPKα pathway 2017 ·Molecular Metabolism ·Dawn Thompson, (unknown), Lindsay A. Grant, (unknown), Kerstin Ziegler, Phillip D. Whitfield, Nimesh Mody, Heather M. Wilson, Mirela Delibegović	29
11	Oxidative costs of reproduction in mouse strains selected for different levels of food intake and which differ in reproductive performance 2016 ·Scientific Reports ·(unknown), Lobke M. Vaanholt, Nimesh Mody, Anis Arnous, Jens Lykkesfeldt, L. Bünger, William G. Hill, Sharon E. Mitchell, David B. Allison, John R. Speakman	17
12	Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction 2014 ·Biochemical Pharmacology ·Abdelali Agouni, Simon Tual‐Chalot, (unknown), Lucie Duluc, Nimesh Mody, Maria Carmen Martínez, Ramaroson Andriantsitohaina, Mirela Delibegović	23
13	Adipocyte-Specific Protein Tyrosine Phosphatase 1B Deletion Increases Lipogenesis, Adipocyte Cell Size and Is a Minor Regulator of Glucose Homeostasis 2012 ·PLoS ONE ·Carl Owen, Alicja Czopek, Abdelali Agouni, Louise Grant, Robert N. Judson, Emma K. Lees, George D. Mcilroy, Olga Göransson, A. Welch, Kendra K. Bence, Barbara B. Kahn, Benjamin G. Neel, Nimesh Mody, Mirela Delibegović	54
14	Susceptibility to diet-induced obesity and glucose intolerance in the APP SWE/PSEN1 A246E mouse model of Alzheimer’s disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein 2011 ·Diabetologia ·Nimesh Mody, Abdelali Agouni, George D. Mcilroy, Bettina Platt, Mirela Delibegović	70
15	In vivo differential effects of fasting, re-feeding, insulin and insulin stimulation time course on insulin signaling pathway components in peripheral tissues 2010 ·Biochemical and Biophysical Research Communications ·Abdelali Agouni, Carl Owen, Alicja Czopek, Nimesh Mody, Mirela Delibegović	32
16	PROTEIN TYROSINE PHOSPHATASE 1B (PTP1B) IN OBESITY AND TYPE 2 DIABETES 2009 ·Mirela Delibegović, Nimesh Mody	5
17	Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistantob/obmice 2008 ·American Journal of Physiology-Endocrinology and Metabolism ·Nimesh Mody, Timothy E. Graham, (unknown), Qin Yang, Barbara B. Kahn	77
18	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes breakdown → 2005 ·Nature ·Qin Yang, Timothy E. Graham, Nimesh Mody, Frédéric Preitner, Odile D. Peroni, Janice M. Zabolotny, Ko Kotani, Loredana Quadro, Barbara B. Kahn	1678
19	Inhibition of N-linked glycosylation of the human type 1α metabotropic glutamate receptor by tunicamycin: effects on cell-surface receptor expression and function 1999 ·Neuropharmacology ·Nimesh Mody, Emmanuel Hermans, Stefan R. Nahorski, R. A. John Challiss	20
20	Clinical Trial of Neoviasept in Amoebiasis 1972 ·(unknown), (unknown), (unknown), Nimesh Mody	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact